19 results
·
24ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
POWDER FREE POLYMER COATED LATEX SURGICAL GLOVES, STERILE (PROTEIN LABELING CLAIM)
FDA 510(k)
FDA Class 1
·General, Plastic Surgery
TB
FDA UDI
Oscor Inc.·00836559009870·
N/A
FDA UDI
BIOMET MICROFIXATION, INC·00841036018726·
ULTRAPOWER
FDA UDI
Conmed Corporation·10845854023938·ULTRAPOWER NEURO GUARD, LONG
A8 INTEGR8® Porous Pedicle Screw System
FDA UDI
ALLUMIN8, INC.·00850080772973·Torque Handle, 12 Nm
Kalitec Special
FDA UDI
Kalitec Direct LLC·B073DRK0100190·SNII Tap, 7.50mm
Intelliguides
FDA UDI
Mios Marketing, LLC·G2710310200190·Talar Osteotmy Guide, 20mm x 19mm
RETROGRADE CARDIOPLEGIA CANNULA, SELF-INFLATING, WITH MALLEABLE OR GUIDEWIRE STYLET
FDA 510(k)
FDA Class 2
·Cardiovascular
SINGLE SIZE TENDON SPACER
FDA 510(k)
FDA Class 2
·Orthopedic
HOMECHOICE
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - LARGO·Product code FKX·March 25, 2013
DRILL, AO SMALL 4.2 X 300 MM
FDA Adverse Event
Malfunction
·STRYKER OSTEOSYNTHESIS KIEL·Product code LXH·March 9, 2011
CD HORIZON SPINAL SYSTEM
FDA Adverse Event
Injury
·WARSAW ORTHOPEDIC INC·Product code NQP·March 27, 2008
TPRLC 133 FP TYPE1 PPS SO 5.0
FDA Adverse Event
Malfunction
·ZIMMER BIOMET, INC.·Product code KWA·May 5, 2020
MENTOR SMOOTH ROUND MODERATE PROFILE
FDA Adverse Event
Injury
·MENTOR TEXAS·Product code FWM·December 16, 2019
PENTAX
FDA Adverse Event
Malfunction
·HOYA CORPORATION PENTAX TOKYO OFFICE·Product code FDT·March 27, 2020
PROLENE BLUE 0.7M 60CM W/NDL
FDA Adverse Event
Malfunction
·ETHICON INC.·Product code GAW·March 11, 2020
Instructions For Use document of the GPS Trackers.
FDA Enforcement
Class II
·Terminated·Blue Ortho·November 4, 2020
Belmont Rapid Infuser, a Fluid Management System, Model FMS2000.
FDA Enforcement
Class II
·Terminated·Belmont Instrument Corporation·October 24, 2012
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014